evertex fabrinology limited

Informe acción TWSE:1470

Capitalización de mercado: NT$1.8b

Salud financiera de hoja de balance de evertex fabrinology

Salud financiera controles de criterios 6/6

evertex fabrinology tiene un patrimonio de accionistas total de NT$1.0B y una deuda total de NT$30.0M, lo que sitúa su ratio deuda-patrimonio en 3%. Sus activos y pasivos totales son NT$1.2B y NT$176.6M respectivamente. El BAIT de evertex fabrinology es de NT$61.6M, por lo que su ratio de cobertura de intereses es de -4.5. Tiene efectivo e inversiones a corto plazo que ascienden a NT$386.9M.

Información clave

3.0%

Ratio deuda-patrimonio

NT$30.00m

Deuda

Ratio de cobertura de intereses-4.5x
EfectivoNT$386.90m
PatrimonioNT$1.00b
Total pasivoNT$176.60m
Activos totalesNT$1.18b

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

Investors Shouldn't Be Too Comfortable With evertex fabrinology's (TWSE:1470) Earnings

Nov 19
Investors Shouldn't Be Too Comfortable With evertex fabrinology's (TWSE:1470) Earnings

evertex fabrinology limited's (TWSE:1470) Business Is Yet to Catch Up With Its Share Price

Sep 16
evertex fabrinology limited's (TWSE:1470) Business Is Yet to Catch Up With Its Share Price

evertex fabrinology's (TWSE:1470) Profits May Not Reveal Underlying Issues

Mar 20
evertex fabrinology's (TWSE:1470) Profits May Not Reveal Underlying Issues

Does evertex fabrinology limited (TPE:1470) Have A Place In Your Dividend Stock Portfolio?

Apr 25
Does evertex fabrinology limited (TPE:1470) Have A Place In Your Dividend Stock Portfolio?

Be Wary Of evertex fabrinology (TPE:1470) And Its Returns On Capital

Mar 26
Be Wary Of evertex fabrinology (TPE:1470) And Its Returns On Capital

evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Mar 05
evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Does evertex fabrinology's (TPE:1470) Statutory Profit Adequately Reflect Its Underlying Profit?

Feb 12
Does evertex fabrinology's (TPE:1470) Statutory Profit Adequately Reflect Its Underlying Profit?

Tread With Caution Around evertex fabrinology limited's (TPE:1470) 4.6% Dividend Yield

Jan 25
Tread With Caution Around evertex fabrinology limited's (TPE:1470) 4.6% Dividend Yield

Would Shareholders Who Purchased evertex fabrinology's (TPE:1470) Stock Year Be Happy With The Share price Today?

Jan 07
Would Shareholders Who Purchased evertex fabrinology's (TPE:1470) Stock Year Be Happy With The Share price Today?

Is evertex fabrinology (TPE:1470) Headed For Trouble?

Dec 20
Is evertex fabrinology (TPE:1470) Headed For Trouble?

evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Dec 02
evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (NT$649.4M) de 1470 superan a sus pasivos a corto plazo (NT$167.3M).

Pasivo a largo plazo: Los activos a corto plazo de 1470 (NT$649.4M) superan a sus pasivos a largo plazo (NT$9.3M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: 1470 tiene más efectivo que su deuda total.

Reducción de la deuda: El ratio deuda-patrimonio de 1470 ha pasado de 4.1% a 3% en los últimos 5 años.

Cobertura de la deuda: La deuda de 1470 está bien cubierta por el flujo de caja operativo (236.7%).

Cobertura de intereses: 1470 gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.


Hoja de balance


Descubre empresas con salud financiera